Heart Failure (HF)
Patient Condition
End-stage dilated cardiomyopathy, LVEF 15%, NYHA class IV, repeatedly hospitalized for cardiogenic shock, and relied on positive inotropic drugs for maintenance. Heart transplant waiting list, but the waiting time is expected to exceed 12 months due to donor shortage.
Treatment Timeline
| Phase | Details | Date |
|---|---|---|
| Assessment of end-stage heart failure | ||
| LVAD implantation | ||
| postoperative rehabilitation | ||
| long-term management |
Treatment Outcome
| before | LVEF 15%, NYHA class IV, dependent on inotropic drugs, unable to complete the 6-minute walk |
|---|---|
| after | LVEF (assisted) effective cardiac output recovery, NYHA class II, free of positive inotropic drugs, 6-minute walking distance of 450m |
| highlight | Patients with end-stage heart failure were successfully freed from positive inotropic drugs after LVAD implantation, and their quality of life was significantly improved |